Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response

Journal of Proteomics

Volumn 75, Issue 10, 2012, Pages 3063-3080

  Ray, Sandipan ^a   Kamath, Karthik S ^a   Srivastava, Rajneesh ^a   Raghu, Dinesh ^a   Gollapalli, Kishore ^a   Jain, Rekha ^a   Gupta, Shipra V ^a   Ray, Sayantan ^d   Taur, Santosh ^b   Dhali, Snigdha ^c   Gogtay, Nithya ^b   Thatte, Urmila ^b   Srikanth, Rapole ^c   Patankar, Swati ^a   Srivastava, Sanjeeva ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b KEM HOSPITAL   (India)

^c NATIONAL CENTRE FOR CELL SCIENCE   (India)

^d MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Disease pathogenesis; Immune response; Plasmodium; Proteomics; Serum; Vivax malaria

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E; CERULOPLASMIN; HAPTOGLOBIN; HEMOPEXIN; PROTEOME; SERUM AMYLOID A; SERUM AMYLOID P;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; INDIA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PATHOGENESIS; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN ISOLATION; PROTEOMICS;

ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PARASITE INTERACTIONS; HUMANS; IMMUNITY; MALARIA, VIVAX; MALE; PLASMODIUM VIVAX; PROTEOME; SEROLOGIC TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 84861347645     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.10.018     Document Type: Article

References (63)

1. World Malaria Report World Health Organization 2008, WHO Press.
2. Park J.W. Changing transmission pattern of Plasmodium vivax malaria in the Republic of Korea: relationship with climate change. Environ Health Toxicol 2011, 26:e2011001.
3. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007, 77:79-87.
4. Shah N.K., Dhillon G.P., Dash A.P., Arora U., Meshnick S.R., Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect Dis 2011, 11:57-64.
5. Mueller I., Galinski M.R., Baird J.K., Carlton J.M., Kochar D.K., Alonso P.L., et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009, 9:555-566.
6. Prajapati S.K., Joshi H., Dev V., Dua V.K. Molecular epidemiology of Plasmodium vivax anti-folate resistance in India. Malar J 2011, 10:102.
7. Lefevre T., Thomas F., Schwartz A., Levashina E., Blandin S., Brizard J.P., et al. Malaria Plasmodium agent induces alteration in the head proteome of their Anopheles mosquito host. Proteomics 2007, 7:1908-1915.
8. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
9. Lasonder E., Janse C.J., van Gemert G.J., Mair G.R., Vermunt A.M., Douradinha B.G., et al. Proteomic profiling of plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog 2008, 4:e1000195.
10. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 2002, 419:520-526.
11. Singh M., Mukherjee P., Narayanasamy K., Arora R., Sen S.D., Gupta S., et al. Proteome analysis of Plasmodium falciparum extracellular secretory antigens at asexual blood stages reveals a cohort of proteins with possible roles in immune modulation and signaling. Mol Cell Proteomics 2009, 8:2102-2118.
12. Prieto J.H., Koncarevic S., Park S.K., Yates J., Becker K. Large scale differential proteome analysis in Plasmodium falciparum under drug treatment. PLoS One 2008, 3:e4098.
13. Ray S., Reddy P.J., Jain R., Gollapalli K., Moiyadi A., Srivastava S. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics 2011, 11:2139-2161.
14. Andrade B.B., Reis-Filho A., Souza-Neto S.M., Raffaele-Netto I., Camargo L.M., Barral A., et al. Plasma Superoxide Dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis 2010, 4:e650.
15. Bahk Y.Y., Na B.K., Cho S.H., Kim J.Y., Lim K.J., Kim T.S. Proteomic analysis of Haptoglobin and Amyloid A protein levels in patients with vivax malaria. Korean J Parasitol 2010, 48:203-211.
16. Jain V., Armah H.B., Tongren J.E., Ned R.M., Wilson N.O., Crawford S., et al. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J 2008, 7:83.
17. Armah H.B., Wilson N.O., Sarfo B.Y., Powell M.D., Bond V.C., Anderson W., et al. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J 2007, 6:147.
18. Scambi C., La Verde V., De Franceschi L., Barausse G., Poli F., Benedetti F., et al. Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of Factor H. PLoS One 2010, 5:e12162.
19. Lee F.W., Lo S.C. The use of Trizol reagent (phenol/guanidine isothiocyanate) for producing high quality two-dimensional gel electrophoretograms (2DE) of dinoflagellates. J Microbiol Methods 2008, 73:26-32.
20. Byrne J.C., Downes M.R., O'Donoghue N., O'Keane C., O'Neill A., Fan Y., et al. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer. J Proteome Res 2009, 8:942-957.
21. Chen Y.Y., Lin S.Y., Yeh Y.Y., Hsiao H.H., Wu C.Y., Chen S.T., et al. A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis 2005, 26:2117-2127.
22. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis. A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
23. Shevchenko A., Tomas H., Havlis J., Olsen J.V., Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006, 1:2856-2860.
24. Thomas P.D., Kejariwal A., Guo N., Mi H., Campbell M.J., Muruganujan A., et al. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acid Res 2006, 34:W645-W650.
25. Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
26. Chen J.H., Chang Y.W., Yao C.W., Chiueh T.S., Huang S.C., Chien K.Y., et al. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry. Proc Natl Acad Sci U S A 2004, 101:17039-17044.
27. Gupta N., Shankernarayan N.P., Dharmalingam K. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin. J Proteome Res 2007, 6:3669-3679.
28. Miller I., Crawford J., Gianazza E. Proteins stains for proteomic applications: which, when, why?. Proteomics 2006, 6:5385-5408.
29. Tannu N.S., Hemby S.E. Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling. Nat Protoc 2006, 1:1732-1742.
30. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
31. Rosales F.J., Topping J.D., Smith J.E., Shankar A.H., Ross A.C. Relation of serum retinol to acute phase proteins and malarial morbidity in Papua New Guinea children. Am J Clin Nutr 2000, 71:1582-1588.
32. Albuquerque L.M., Trugilho M.R., Chapeaurouge A., Jurgilas P.B., Bozza P.T., Bozza F.A., et al. Two dimensional difference gel electrophoresis (DIGE) analysis of plasmas from dengue fever patients. J Proteome Res 2009, 8:5431-5441.
33. Francischetti Ivo M.B. Does activation of the blood coagulation cascade play a role in malaria pathogenesis. Trends Parasitol 2008, 24:258-263.
34. Phanuphak P., Hanvanich M., Sakulramrung R., Moollaor P., Sitprija V., Phanthumkosol D. Complement changes in falciparum malaria infection. Clin Exp Immunol 1985, 59:571-576.
35. Thurnham D.I., Singkamani R. The acute phase response and vitamin A status in malaria. Trans R Soc Trop Med Hyg 1991, 85:194-199.
36. Taylor-Robinson A.W. Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection. Parasitol Int 2000, 48:297-301.
37. Pied S., Tabone M.D., Chatellier G., Marussig M., Jardel C., Nosten F., et al. Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. Parasite 1995, 2:263-268.
38. Balmer P., McMonagle F., Alexander J., Phillips S. Experimental erythrocytic malaria infection induces elevated serum amyloid P production in mice. Immunol Lett 2000, 72:147-152.
39. Hutchcraft C.L., Gewurz H., Hansen B., Dyck R.F. Agglutination of complement-coated erythrocytes by serum amyloid P-component. J Immunol 1981, 126:1217-1219.
40. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994, 15:81-88.
41. Malle E., Sodin-Semrl S., Kovacevic A. Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci 2009, 66:9-26.
42. Delanghe J.R., Langlois M.R. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 2001, 312:13-23.
43. Ferreira A., Balla J., Jeney V., Balla G. A central role for free heme in the pathogenesis of severe malaria: the missing link?. J Mol Med 2008, 86:1097-1111.
44. Erel O., Kocyigit A., Avci S., Aktepe N., Bulut V. Oxidative stress and antioxidative status of plasma and erythrocytes in patients with vivax malaria. Clin Biochem 1997, 30:631-639.
45. McGuire W., D'Alessandro U., Olaleye B.O., Thomson M.C., Langerock P., Greenwood B.M., et al. C-reactive protein and haptoglobin in the evaluation of a community-based malaria control programme. Trans R Soc Trop Med Hyg 1996, 90:10-14.
46. Baumann H., Gauldie J. The acute phase response. Immunol Today 1994, 15:74-80.
47. Rougemont A., Dumbo O., Bouvier M., Soula G., Perrin L., Tamoura B., et al. Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West Africa. Lancet 1988, 2:709-712.
48. Yerly S., Bouvier M., Rougemont A., Srivastava I., Perrin L.H. Development of a haptoglobin ELISA. Its use as an indicator for malaria. Acta Trop 1990, 47:237-244.
49. Mohapatra M.K., Mohanty S., Mohanty B.K., Sahu G.N. Hypohaptoglobinaemia as a biochemical and epidemiological marker of falciparum malaria. J Assoc Physicians India 1999, 47:874-877.
50. Tabone M.D., Muanza K., Lyagoubi M., Jardel C., Pied S., Amedee-Manesme O., et al. The role of interleukin-6 in vitamin A deficiency during Plasmodium falciparum malaria and possible consequences for vitamin A supplementation. Immunology 1992, 75:553-554.
51. Das B.S., Thurnham D.I., Das D.B. Plasma a-tocopherol, retinol and carotenoids in children with falciparum malaria. Am J Clin Nutr 1996, 64:94-100.
52. Shulman C.E., Marshall T., Dorman E.K., Bulmer J.N., Cutts F., Peshu N., et al. Malaria in pregnancy: adverse effects on haemoglobin levels and birth weight in primigravidae and multigravidae. Trop Med Int Health 2001, 6:770-778.
53. Simpson D.C., Kabyemela E., Muehlenbachs A., Ogata Y., Mutabingwa T.K., Duffy P.E., et al. Plasma levels of Apolipoprotein A1 in malaria exposed primigravidae are associated with severe anemia. PLoS One 2010, 5:e8822.
54. Ganguly N.K., Chandanani R.E., Mahajan R.C., Sharma S. Immunoglobulins and C3 levels in Plasmodium vivax infection and their relationship to haemagglutination antibody titres. Indian J Med Res 1980, 71:505.
55. Wenisch C., Spitzauer S., Florris-Linau K., Rumpold H., Vannaphan S., Parschalk B., et al. Complement activation in severe Plasmodium falciparum malaria. Clin Immunol Immunopathol 1997, 85:166-171.
56. Neva F.A., Howard W.A., Glew R.H., Krotoski W.A., Gam A.A., Collins W.E., et al. Relationship of serum complement levels to events of the malarial paroxysm. J Clin Invest 1974, 54:451-460.
57. Nyakoe N.K., Taylor R.P., Makumi J.N., Waitumbi J.N. Complement consumption in children with Plasmodium falciparum malaria. Malar J 2009, 8:7.
58. Matsushita M., Kuraya M., Hamasaki N., Tsujimura M., Shiraki H., Fujita T. Activation of the lectin complement pathway by H-Ficolin (Hakata Antigen). J Immunol 2002, 168:3502-3506.
59. Garred P., Nielsen M.A., Kurtzhals J.A., Malhotra R., Madsen H.O., Goka B.Q., et al. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 2003, 71:5245-5253.
60. Yamaguchi S., Kubota T., Yamagishi T., Okamoto K., Izumi T., Takada M., et al. Severe thrombocytopenia suggesting immunological mechanisms in two cases of vivax malaria. Am J Hematol 1997, 56:183-186.
61. Loke H., Bethell D., Phuong C.X., Day N., White N., Farrar J., et al. Susceptibility to dengue hemorrhagic fever in Vietnam:evidence of association with variation in the vitamin d receptor and Fc gamma receptor lla genes. Am J Trop Med Hyg 2002, 67:102-106.
62. Vial H.J., Thuet M.J., Phillippot J.R. Inhibition of the in vitro growth of Plasmodium falciparum by D vitamins and vitamin D-3 derivatives. Mol Biochem Parasitol 1982, 5:189-198.
63. Muller S., Kappes B. Vitamin and co-factor biosynthesis pathways in Plasmodium and other apicomplexan parasites. Trends Parasitol 2007, 23:112-121.